RU2227033C2 - Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита - Google Patents

Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита

Info

Publication number
RU2227033C2
RU2227033C2 RU2001107149/15A RU2001107149A RU2227033C2 RU 2227033 C2 RU2227033 C2 RU 2227033C2 RU 2001107149/15 A RU2001107149/15 A RU 2001107149/15A RU 2001107149 A RU2001107149 A RU 2001107149A RU 2227033 C2 RU2227033 C2 RU 2227033C2
Authority
RU
Russia
Prior art keywords
combination
taurolidine
taurultam
helicobacter
microorganisms
Prior art date
Application number
RU2001107149/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2001107149A (ru
Inventor
Рольф ПФИРРМАНН (CH)
Рольф ПФИРРМАНН
Original Assignee
Эд Гейштлих Зёне Аг Фюр Хемише Индустрие
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эд Гейштлих Зёне Аг Фюр Хемише Индустрие filed Critical Эд Гейштлих Зёне Аг Фюр Хемише Индустрие
Publication of RU2001107149A publication Critical patent/RU2001107149A/ru
Application granted granted Critical
Publication of RU2227033C2 publication Critical patent/RU2227033C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2001107149/15A 1998-09-16 1999-09-13 Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита RU2227033C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15445198A 1998-09-16 1998-09-16
US09/154,451 1998-09-16
US09/316,115 1999-05-20
US09/316,115 US6117868A (en) 1998-09-16 1999-05-20 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection

Publications (2)

Publication Number Publication Date
RU2001107149A RU2001107149A (ru) 2003-04-20
RU2227033C2 true RU2227033C2 (ru) 2004-04-20

Family

ID=26851461

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001107149/15A RU2227033C2 (ru) 1998-09-16 1999-09-13 Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита

Country Status (8)

Country Link
US (1) US6117868A (enExample)
EP (1) EP1112074B1 (enExample)
JP (1) JP4981208B2 (enExample)
CA (1) CA2344308C (enExample)
DE (1) DE69916629T2 (enExample)
ES (1) ES2219061T3 (enExample)
RU (1) RU2227033C2 (enExample)
WO (1) WO2000015232A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010114425A2 (ru) 2009-03-30 2010-10-07 Dikovskiy Aleksander Vladimirovich Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки
RU2576511C2 (ru) * 2010-02-24 2016-03-10 Эмисфире Текнолоджис, Инк. Пероральная терапия недостаточности витамина в12

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) * 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US8030301B2 (en) * 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7892530B2 (en) * 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
JP2001122777A (ja) * 1999-10-27 2001-05-08 Nagase & Co Ltd 抗潰瘍剤
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP2003515558A (ja) * 1999-12-06 2003-05-07 ロード アイランド ホスピタル， ア ライフスパン パートナー 腫瘍を治療するためのメチロール含有化合物の使用
FR2803206A1 (fr) * 1999-12-30 2001-07-06 Aventis Pharma Sa Composition comprenant des acides nucleiques, preparation et utilisation
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
US6753328B2 (en) 2001-10-01 2004-06-22 Rhode Island Hospital Methods of inhibiting metastases
FI20021819A0 (fi) * 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
JP2007537200A (ja) * 2004-05-14 2007-12-20 ハンス−ディートリヒ・ポラシェグ タウロリジン製剤及び投与：細菌マイクロフィルム形成に対する治療処置及び抗菌保護
ES2372429T3 (es) * 2006-12-20 2012-01-19 Kyowa Chemical Industry Co., Ltd. Antiácido.
EP2601947A1 (en) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
PL2861573T3 (pl) 2012-06-18 2018-02-28 Geistlich Pharma Ag Pochodne oksatiazyny jako środki przeciwbakteryjne i przeciwnowotworowe
KR20180105115A (ko) * 2015-10-07 2018-09-27 코르메딕스, 인코포레이티드 타우로리딘의 피부-침투성 제제
CN117159461A (zh) * 2023-07-26 2023-12-05 合肥远志医药科技开发有限公司 一种铝碳酸镁混悬液及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077281A (en) * 1985-09-20 1991-12-31 Reinmueller Johannes Novel use of taurolin
RU2025128C1 (ru) * 1989-01-19 1994-12-30 ШМИДТ Альфред Средство для лечения воспалительных заболеваний пищевода и воспалительных и язвенных заболеваний желудочно-кишечного тракта
WO1996024375A1 (en) * 1995-02-06 1996-08-15 Astra Aktiebolag New oral pharmaceutical dosage form
WO1997036599A1 (en) * 1996-03-29 1997-10-09 Marcin Krotkiewski Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
IL105155A (en) * 1992-04-24 1999-05-09 Astra Ab Combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
JPH09121890A (ja) * 1995-10-30 1997-05-13 Mitsubishi Kagaku B C L:Kk ヘリコバクター属細菌の検出方法
JPH1017471A (ja) * 1996-07-04 1998-01-20 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物系併用医薬
JP3677376B2 (ja) * 1996-08-13 2005-07-27 武田薬品工業株式会社 医薬
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077281A (en) * 1985-09-20 1991-12-31 Reinmueller Johannes Novel use of taurolin
RU2025128C1 (ru) * 1989-01-19 1994-12-30 ШМИДТ Альфред Средство для лечения воспалительных заболеваний пищевода и воспалительных и язвенных заболеваний желудочно-кишечного тракта
WO1996024375A1 (en) * 1995-02-06 1996-08-15 Astra Aktiebolag New oral pharmaceutical dosage form
WO1997036599A1 (en) * 1996-03-29 1997-10-09 Marcin Krotkiewski Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Реферат из АБД Medline: Focht J et al. [1996 pathogen incidence and resistance status in peritonitis] Langenbecks Arch Chir. 1997; 382(4 Suppl 1):S1-4. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010114425A2 (ru) 2009-03-30 2010-10-07 Dikovskiy Aleksander Vladimirovich Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12- перстной кишки
RU2576511C2 (ru) * 2010-02-24 2016-03-10 Эмисфире Текнолоджис, Инк. Пероральная терапия недостаточности витамина в12

Also Published As

Publication number Publication date
DE69916629T2 (de) 2004-08-12
CA2344308C (en) 2008-05-20
WO2000015232A1 (en) 2000-03-23
US6117868A (en) 2000-09-12
DE69916629D1 (de) 2004-05-27
EP1112074B1 (en) 2004-04-21
ES2219061T3 (es) 2004-11-16
CA2344308A1 (en) 2000-03-23
EP1112074A1 (en) 2001-07-04
JP2002525266A (ja) 2002-08-13
JP4981208B2 (ja) 2012-07-18

Similar Documents

Publication Publication Date Title
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
RU2001107149A (ru) Тауролидин и/или таурултам против инфекционной язвенной болезни или инфекционного гастрита
CA2506930C (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
US11110209B2 (en) Intraluminal therapy system for gastrointestinal infections
EP0637241A1 (en) Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
US20040131676A1 (en) Dosage forms containing a PPI, NSAID, and buffer
US20090075950A1 (en) Dosage Forms Containing A PPI, NSAID And A Buffer
JP2002525266A5 (enExample)
UA120249C2 (uk) Фармацевтичні композиції для лікування від helicobacter pylori
KR20040089628A (ko) 생체내에서 상전이하는 액상 매트릭스 및 액상 경구 제제
RU2025128C1 (ru) Средство для лечения воспалительных заболеваний пищевода и воспалительных и язвенных заболеваний желудочно-кишечного тракта
JP2004534050A (ja) 細胞ストレスに関連する疾病及び状態を予防及び治療する方法
US20020146451A1 (en) Method for the administration of acid-labile drugs
KR19990023021A (ko) 신규한 의약 용도
US5618564A (en) Composition for the treatment of helicobacter pylori infection
AU8424091A (en) Pharmaceutical compositions containing 5-difluoromethoxy-2-{(3,4-dimethoxy-2-pyridyl) methylsulfinyl} benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
US5834004A (en) Enteral composition comprising dimethicone and a photosensitizer and a method of delivery
WO2010092436A1 (en) Pharmaceutical combinations of simethicone and otilonium
WO1998013041A1 (en) Prophylaxis and treatment of intestinal tract fluid and electrolyte loss using histidine compositions
EP0219912A2 (en) The use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
ES2356371T3 (es) Medicamentos terapéuticos para inducir tolerancia.
KR102289089B1 (ko) 인후두 역류질환 치료 또는 예방용 조성물
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
CN1753674A (zh) 泰妥拉唑在治疗胃食管反流性疾病中的应用
US20040146554A1 (en) Method for the administration of acid-labile drugs

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100914